Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Authors GuideSubmit manuscript

Outline

https://doi.org/10.5812/hepatmon.66419

WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens

Authors

Jamshid VafaeimaneshJamshid Vafaeimanesh ORCID1, 2, Fahimeh Safarnezhad TameshkelFahimeh Safarnezhad Tameshkel ORCID1, Hossein Ajdarkosh1, Azita Azarkeyvani3, Mahmoodreza Khoonsari1, Amirhossein Faraji1, Masoudreza Sohrabi1, Sima Aten1, Hossein KeyvaniHossein Keyvani ORCID1, Farhad Zamani1,*
1Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, IR Iran
2Gastroenterology and Hepatology Disease Research Center, Qom University of Medical Sciences, Qom, IR Iran
3Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Department of Thalassemia Clinic, Tehran, IR Iran
*Corresponding Author: Corresponding author: Farhad Zamani, Gastrointestinal and Liver Disease Research Center, Iran University of Medical Sciences, Tehran, IR Iran. E-mail: Email: [email protected]
Hepatitis Monthly:Vol. 18, issue 9; e66419
Published online:Jul 11, 2018
Article type:Research Article
Received:Jan 17, 2018
Accepted:Jun 09, 2018
How to Cite:Vafaeimanesh J, Safarnezhad Tameshkel F, Ajdarkosh H, Azarkeyvani A, Khoonsari M, et al. WITHDRAWN: Efficacy and Side Effects of Sofosbuvir and Daclatasvir for Treatment of Hepatitis C in Thalassemia Major Patients with Treatment Experience of Interferon-Based Regimens. Hepat Mon. 2018;18(9):e66419. doi: https://doi.org/10.5812/hepatmon.66419

Withdrawal Note

This article is withdrawn by EIC - on behalf of the editorial board- because of the case that it was published simultaneously in another journal (https://www.ncbi.nlm.nih.gov/pubmed/30084415). After the investigation raised by EIC, authors confessed to their mistake in double submission (#346818) and due to the status of the article (In Press) and journal policy about withdrawal regulations (http://hepatmon.com/en/knowledgebase/category/tree.html#withdrawal_regulations.html), we decided to withdraw it from our journal.

Copyright

Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Similar Articles

8
Mar
2017

Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3”

Babak Sayad,
Fatemeh Norooznezhad,
Alireza Farokhi
PDF

Sayad B, Norooznezhad F, Farokhi A. Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3”. Hepat Mon. 2017;17(3):e58720. doi: https://doi.org/10.5812/hepatmon.46588

17
Jul
2016

Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: The First Case Report

Nawfal R Hussein
PDF

Hussein NR. Sofosbuvir-Containing Regimen for the Treatment of Hepatitis C Virus in a Patient With Sickle-Thalassemia: The First Case Report. Int J Infect. 2017;4(1):e38077. doi: https://doi.org/10.17795/iji-38077

31
Jan
2012

Sustained Viral Response and Hematological Adverse Events During Chronic Hepatitis C Infection Treatment

Mortada El-Shabrawi,
Mortada El-Shabrawi,
Mona Isa,
Mona Isa
PDF

El-Shabrawi M, El-Shabrawi M, Isa M, Isa M. Sustained Viral Response and Hematological Adverse Events During Chronic Hepatitis C Infection Treatment. Hepat Mon. 2012;12(2):. doi: https://doi.org/10.5812/hepatmon.829

28
Aug
2016

Sustained Virological Response After Six Weeks Treatment with a Sofosbuvir-Containing Regimen in a Patient Infected with Hepatitis C Virus Genotype 4: A Case Report

Nawfal R Hussein
PDF

Hussein NR. Sustained Virological Response After Six Weeks Treatment with a Sofosbuvir-Containing Regimen in a Patient Infected with Hepatitis C Virus Genotype 4: A Case Report. Int J Infect. 2017;4(3):e41216. doi: https://doi.org/10.5812/iji.41216

30
Jun
2012

Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks

Roberta DAmbrosio,
Alessio Aghemo
PDF

DAmbrosio R, Aghemo A. Treatment of Patients With HCV Related Cirrhosis: Many Rewards With Very Few Risks. Hepat Mon. 2012;12(6):. doi: https://doi.org/10.5812/hepatmon.6095

More by these authors

Jamshid VafaeimaneshPubMedScholar
Fahimeh Safarnezhad TameshkelPubMedScholar
Hossein AjdarkoshPubMedScholar
Azita AzarkeyvaniPubMedScholar
Mahmoodreza KhoonsariPubMedScholar
Amirhossein FarajiPubMedScholar
Masoudreza SohrabiPubMedScholar
Sima AtenPubMedScholar
Hossein KeyvaniPubMedScholar
Farhad ZamaniPubMedScholar

Find related work

PubMed
Google Scholar
Create citation alert
Download PDF58.52 KB
Import into EndNoteImport into BibTex
Share
Cited by
Metrics
Comments
Number of Comments:0